학술논문
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
Document Type
Article
Author
Fleischer, D.M.; Greenhawt, M.; Shreffler, W.G.; Campbell, D.E.; Ford, L.S.; Green, T.D.; Lambert, R.; Peillon, A.; Bois, T.; Sampson, H.A.; Chong, H.J.; Anvari, S.; Davis, C.M.; Assa'ad, A.; Bégin, P.; Beyer, K.; Bird, J.A.; Brown-Whitehorn, T.; Byrne, A.; Chan, E.S.; Cheema, A.; Chinthrajah, S.; Gagnon, R.; Hourihane, J.O.; Jones, S.M.; Kim, E.H.; Lange, L.; Lanser, B.J.; Leonard, S.; Mahler, V.; Maronna, A.; Nowak-Wegrzyn, A.; Oriel, R.C.; O'Sullivan, M.; Prescott, S.L.; Petroni, D.; Pongracic, J.A.; Schneider, L.C.; Smith, P.; Staab, D.; Sussman, G.; Wood, R.; Yang, W.H.
Source
In: Journal of Allergy and Clinical Immunology . (Journal of Allergy and Clinical Immunology, October 2020, 146(4):863-874)
Subject
Language
English
ISSN
10976825
00916749
00916749